| Date Filed | Type | Description |
| 03/28/2019 |
GN
| Factors of Influence in 2019, Key Indicators and Opportunity within The Ultimate Software Group, New Mountain Finance, Denny's, World Fuel Services, Agree Realty, and Acceleron Pharma — New Research Emphasizes Economic Growth |
| 10/24/2018 |
GN
| Research Report Identifies Cato, Roadrunner Transportation, Talend S.A, Vi, MannKind, and Acceleron Pharma with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
| 05/08/2018 |
BW
| Acceleron Reports First Quarter 2018 Operating and Financial Results |
| 04/30/2018 |
BW
| Acceleron to Webcast First Quarter 2018 Operating and Financial Results on May 8, 2018 |
| 02/27/2018 |
BW
| Acceleron Reports Fourth Quarter and Full Year 2017 Operating and Financial Results |
| 02/20/2018 |
BW
| Acceleron to Webcast Fourth Quarter and Full Year 2017 Operating and Financial Results on February 27, 2018 |
| 01/17/2018 |
GN
| Consolidated Research: 2018 Summary Expectations for Eclipse Resources, Unit, Post, Acceleron Pharma, SELECT EGY SVCS, and Concho Resources — Fundamental Analysis, Key Performance Indications |
| 01/02/2018 |
BW
| Acceleron to Webcast Presentation at the 36th Annual J.P. Morgan Healthcare Conference |
| 12/10/2017 |
BW
| Acceleron Announces Updated Results from Ongoing Phase 2 Trials of Luspatercept in Myelodysplastic Syndromes at the 59th Annual Meeting of the American Society of Hematology |
| 12/05/2017 |
BW
| Acceleron to Host Conference Call and Webcast to Review Data Presented at the 59th American Society of Hematology Annual Meeting and Exposition |
| 11/07/2017 |
BW
| Acceleron Pharma Reports Third Quarter 2017 Operational and Financial Results |
| 10/26/2017 |
BW
| Acceleron to Webcast Third Quarter 2017 Financial Results on November 7, 2017 |
| 09/19/2017 |
BW
| Acceleron to Develop Sotatercept in Pulmonary Arterial Hypertension |
| 09/12/2017 |
BW
| Acceleron to Host Research and Development Day on September 19, 2017 |
| 08/03/2017 |
BW
| Acceleron Pharma Reports Second Quarter 2017 Operational and Financial Results |
| 07/27/2017 |
BW
| Acceleron to Webcast Second Quarter 2017 Financial Results on August 3, 2017 |
| 05/08/2017 |
BW
| Acceleron Pharma Reports First Quarter 2017 Operational and Financial Results |
| 05/06/2017 |
BW
| Luspatercept Phase 2 Data Presented at the 14th International Symposium on Myelodysplastic Syndromes |
| 05/01/2017 |
BW
| Acceleron to Participate in Two Healthcare Investor Conferences in May |
| 04/26/2017 |
BW
| Acceleron to Host Webcast to Review First Quarter 2017 Financial and Operational Results on May 8, 2017 |
| 03/16/2017 |
BW
| Acceleron Announces Plans to Initiate a Phase 2 Trial of ACE-083 in Charcot-Marie-Tooth Neuromuscular Disease and Host Educational Webinar |